AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24259553 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g eicosapentaenoic acid (EPA) + 1 g docosahexaenoic acid
Number of subjects: 83
Study 24259553 — intervention group
Group type: COMPARATOR
Intervention: Corn/soybean oil placebo
Number of subjects: 83
Study 23752109 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab for 1 year
Number of subjects: 3401
Study 23752109 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 3401
Study 19404694 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-free chlorhexidine (CHX)
Number of subjects: 20
Study 19404694 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oils (EO)
Number of subjects: 20
Study 19404694 — intervention group
Group type: COMPARATOR
Intervention: Water (negative control)
Number of subjects: 20
Study 18492953 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 668
Study 18492953 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 668
Study 15705012 — intervention group
Group type: EXPERIMENTAL
Intervention: Yi-Gan San (YGS) for 4 weeks
Number of subjects: 52
Study 15705012 — intervention group
Group type: COMPARATOR
Intervention: Control (drug-free) for 4 weeks
Number of subjects: 52
Study 12742483 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus (target level 12 to 15 ng/mL in the first month)
Number of subjects: 85
Study 12742483 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus (target level 12 to 18 ng/mL in the first month)
Number of subjects: 85
Study 12742483 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 85
Study 10463905 — intervention group
Group type: EXPERIMENTAL
Intervention: Patulin for the common cold (controlled, double blind mass trial)
Number of subjects: 0
Study 10463905 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptomycin (first trial, not double blind or placebo controlled)
Number of subjects: 0
Study 8671965 — intervention group
Group type: EXPERIMENTAL
Intervention: ANP infusion (0.005 microg/kg*min; group II, n=15)
Number of subjects: 31
Study 8671965 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group III, n=16)
Number of subjects: 31
Study 8671965 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (group I, n=10)
Number of subjects: 31
Study 1834065 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil 4 mg i.v.
Number of subjects: 20
Study 1834065 — intervention group
Group type: COMPARATOR
Intervention: Glyceryl trinitrate (GTN) 0.3 mg i.v.
Number of subjects: 20
Study 7134845 — intervention group
Group type: EXPERIMENTAL
Intervention: 3:1 jejunoileal bypass
Number of subjects: 34
Study 7134845 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:3 jejunoileal bypass
Number of subjects: 34
Study 7134845 — intervention group
Group type: COMPARATOR
Intervention: Unoperated group
Number of subjects: 34
Study 30227147 — intervention group
Group type: EXPERIMENTAL
Intervention: High expectation priming
Number of subjects: 88
Study 30227147 — intervention group
Group type: EXPERIMENTAL
Intervention: Low expectation priming
Number of subjects: 88
Study 30227147 — intervention group
Group type: EXPERIMENTAL
Intervention: Active stimulation with low expectation priming
Number of subjects: 88
Study 30227147 — intervention group
Group type: COMPARATOR
Intervention: Sham-controlled anodal tDCS
Number of subjects: 88
Study 26482574 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centered physical therapy
Number of subjects: 70
Study 25133491 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA) 5% and phenylephrine 0.5%
Number of subjects: 60
Study 25133491 — intervention group
Group type: COMPARATOR
Intervention: Control group with phenylephrine 0.5%
Number of subjects: 60
Study 22233253 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocyte-derived dendritic cells pulsed with inactivated HIV-1 autologous virus
Number of subjects: 0
Study 22233253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20346030 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave lithotripsy (ESWL)
Number of subjects: 273
Study 20346030 — intervention group
Group type: COMPARATOR
Intervention: Ureteroscopy (URS)
Number of subjects: 273
Study 18177775 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral ampicillin (100 mg/kg per day in four doses for 48 hours, followed by 3 days of oral amoxicillin (80-90 mg/kg per day); n=1012
Number of subjects: 2037
Study 18177775 — intervention group
Group type: COMPARATOR
Intervention: Home-based treatment with oral amoxicillin (80-90 mg/kg per day in two doses for 5 days; n=1025
Number of subjects: 2037
Study 18177775 — intervention group
Group type: COMPARATOR
Intervention: Ambulatory group
Number of subjects: 2037
Study 18177775 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalised group
Number of subjects: 2037
Study 15797885 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone plus psychotherapy treatment
Number of subjects: 336
Study 15797885 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy treatment alone
Number of subjects: 336
Study 12748428 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 11026862 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder volume of 100 ml
Number of subjects: 30
Study 11026862 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder volume of 70 ml
Number of subjects: 30
Study 11026862 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder volume of 35 ml
Number of subjects: 30
Study 11026862 — intervention group
Group type: COMPARATOR
Intervention: Empty bladder
Number of subjects: 30
Study 8989778 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated cytology rescreening of Pap smears
Number of subjects: 0
Study 8989778 — intervention group
Group type: EXPERIMENTAL
Intervention: High-resolution imaging techniques and computer classifiers
Number of subjects: 0
Study 1618997 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine (120 mg oral)
Number of subjects: 9
Study 1618997 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 4038550 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous droperidol
Number of subjects: 23
Study 4038550 — intervention group
Group type: COMPARATOR
Intervention: Combination of promethazine and chlorpromazine rectal suppositories
Number of subjects: 23
Study 31699728 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing Aid software integrating research reporting guidelines
Number of subjects: 54
Study 28082368 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of conservative therapies including education for joint protection and OA, a splint for the base of the thumb, hand exercises, and topical diclofenac sodium 1% gel over 6 weeks.
Number of subjects: 204
Study 28082368 — intervention group
Group type: COMPARATOR
Intervention: Education for joint protection and OA alone (Control group).
Number of subjects: 204
Study 28082368 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of conservative therapies (Intervention group).
Number of subjects: 204
Study 27096878 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased physical activity (200 minutes per week) for 7 years in girls
Number of subjects: 364
Study 27096878 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased physical activity (200 minutes per week) for 7 years in boys
Number of subjects: 364
Study 27096878 — intervention group
Group type: COMPARATOR
Intervention: Control group (60 minutes per week) for 7 years in boys
Number of subjects: 364
Study 24937669 — intervention group
Group type: EXPERIMENTAL
Intervention: DEB-TACE
Number of subjects: 177
Study 24937669 — intervention group
Group type: COMPARATOR
Intervention: cTACE
Number of subjects: 177
Study 22190136 — intervention group
Group type: EXPERIMENTAL
Intervention: 8‐week formula weight‐loss diet 415‐810 kcal per day, followed by 8 weeks on a hypo‐energetic 1200 kcal per day diet
Number of subjects: 192
Study 20567133 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol 150 microg
Number of subjects: 50
Study 20567133 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol 300 microg
Number of subjects: 50
Study 20567133 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol 600 microg
Number of subjects: 50
Study 20567133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 17552374 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaboxadol 5 mg (GBX5)
Number of subjects: 109
Study 17552374 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaboxadol 10 mg (GBX10)
Number of subjects: 109
Study 17552374 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaboxadol 15 mg (GBX15)
Number of subjects: 109
Study 17552374 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg (ZOL10)
Number of subjects: 109
Study 17552374 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 109
Study 15769761 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive treatment strategy
Number of subjects: 2183
Study 15769761 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-protocol-guided care
Number of subjects: 2183
Study 15769761 — intervention group
Group type: COMPARATOR
Intervention: Invasive strategy
Number of subjects: 2183
Study 11130129 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA with propofol (4 mg/kg/h) and remifentanil (0.25 microgram/kg/min)
Number of subjects: 22
Study 11130129 — intervention group
Group type: COMPARATOR
Intervention: TIVA with propofol (4 mg/kg/h) and sufentanil (1 microgram/kg)
Number of subjects: 22
Study 9175664 — intervention group
Group type: EXPERIMENTAL
Intervention: Closure of subcutaneous fat tissue
Number of subjects: 164
Study 9175664 — intervention group
Group type: COMPARATOR
Intervention: No closure of subcutaneous fat tissue
Number of subjects: 164
Study 1606772 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide for 6 months, warfarin and dipyridamole for two years
Number of subjects: 40
Study 1606772 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 40
Study 2581010 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (PTX)
Number of subjects: 10
Study 31908212 — intervention group
Group type: EXPERIMENTAL
Intervention: SurgeMan®
Number of subjects: 45
Study 31908212 — intervention group
Group type: COMPARATOR
Intervention: TraumaMan®
Number of subjects: 45
Study 31908212 — intervention group
Group type: COMPARATOR
Intervention: Porcine models
Number of subjects: 45
Study 31908212 — intervention group
Group type: EXPERIMENTAL
Intervention: All three models
Number of subjects: 45
Study 29361834 — intervention group
Group type: COMPARATOR
Intervention: High-Intensity Resistance Training (HIGH)
Number of subjects: 103
Study 29361834 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Resistance Training (MOD)
Number of subjects: 103
Study 29361834 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 103
Study 29361834 — intervention group
Group type: COMPARATOR
Intervention: Exercise Groups (HIGH and MOD)
Number of subjects: 103
Study 27349668 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM-based exercise counseling combined with music skipping rope exercise for 12 weeks
Number of subjects: 75
Study 27349668 — intervention group
Group type: COMPARATOR
Intervention: One session of exercise counseling with music skipping rope exercise for 12 weeks
Number of subjects: 75
Study 23733767 — intervention group
Group type: EXPERIMENTAL
Intervention: Schedule A: decitabine 20 mg/m² SC per day for 3 consecutive days on days 1, 2, and 3 every 28 days
Number of subjects: 65
Study 23733767 — intervention group
Group type: COMPARATOR
Intervention: Schedule B: decitabine 20 mg/m² SC per day once every 7 days on days 1, 8, and 15 every 28 days
Number of subjects: 65
Study 23733767 — intervention group
Group type: EXPERIMENTAL
Intervention: Schedule A
Number of subjects: 65
Study 23733767 — intervention group
Group type: COMPARATOR
Intervention: Schedule B
Number of subjects: 65
Study 20496049 — intervention group
Group type: EXPERIMENTAL
Intervention: 2:1 diet
Number of subjects: 24
Study 20496049 — intervention group
Group type: EXPERIMENTAL
Intervention: 10:1 + S diet
Number of subjects: 24
Study 20496049 — intervention group
Group type: COMPARATOR
Intervention: 10:1 diet
Number of subjects: 24
Study 20496049 — intervention group
Group type: EXPERIMENTAL
Intervention: 2:1 + S diet
Number of subjects: 24
Study 18925510 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion volume of 10 ml/kg
Number of subjects: 20
Study 18925510 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion volume of 15 ml/kg
Number of subjects: 20
Study 18925510 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 20
Study 16649866 — intervention group
Group type: EXPERIMENTAL
Intervention: Unresolved trauma
Number of subjects: 60
Study 12790159 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg of melatonin
Number of subjects: 10
Study 12790159 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg of melatonin
Number of subjects: 10
Study 12790159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 10781447 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream (5 g per chest tube cutaneously 3 h before CTR)
Number of subjects: 120
Study 10781447 — intervention group
Group type: COMPARATOR
Intervention: IV morphine (0.1 mg/kg up to 10 mg IV 30 min before CTR)
Number of subjects: 120
Study 8882074 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 50 micrograms twice daily
Number of subjects: 29
Study 8882074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 1430301 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning dose of 200 mg valproic acid (VPA) after a light meal
Number of subjects: 16
Study 1430301 — intervention group
Group type: COMPARATOR
Intervention: Evening dose of 200 mg valproic acid (VPA) after a heavy meal
Number of subjects: 16
Study 1430301 — intervention group
Group type: COMPARATOR
Intervention: Evening dose of 200 mg valproic acid (VPA) after a light meal
Number of subjects: 16
Study 3005756 — intervention group
Group type: EXPERIMENTAL
Intervention: Short‐acting steroid (fluocortolone or prednisone) on three out of four days
Number of subjects: 31
Study 3005756 — intervention group
Group type: COMPARATOR
Intervention: Daily steroid treatment (15 mg prednisone or more per day)
Number of subjects: 31
Study 3005756 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 31
Study 30089116 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated mathematics/geometry and physical activity program (experimental group, n1 = 19)
Number of subjects: 36
Study 30089116 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching methods (control group, n2 = 17)
Number of subjects: 36
Study 27339562 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-based learning
Number of subjects: 146
Study 27339562 — intervention group
Group type: COMPARATOR
Intervention: Lecture-based learning
Number of subjects: 146
Study 24656872 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of fruits (80 g) and vegetables (60 g)
Number of subjects: 388
Study 24656872 — intervention group
Group type: COMPARATOR
Intervention: Family income higher than four minimum wages
Number of subjects: 388
Study 24656872 — intervention group
Group type: COMPARATOR
Intervention: Lower paternal educational level
Number of subjects: 388
Study 24656872 — intervention group
Group type: COMPARATOR
Intervention: Lower fruit consumption at 12-16 months
Number of subjects: 388
Study 24656872 — intervention group
Group type: COMPARATOR
Intervention: Consumption of high-sugar content beverages at 12-16 months
Number of subjects: 388
Study 22069111 — intervention group
Group type: EXPERIMENTAL
Intervention: DWI group (echo‐planar DW stimulation)
Number of subjects: 51
Study 22069111 — intervention group
Group type: EXPERIMENTAL
Intervention: T1 group (T1‐weighted stimulation)
Number of subjects: 51
Study 22069111 — intervention group
Group type: COMPARATOR
Intervention: Sham group (no magnetic stimulation)
Number of subjects: 51
Study 22069111 — intervention group
Group type: COMPARATOR
Intervention: Comparison of MR stimulation (DWI or T1) vs. sham group
Number of subjects: 51
Study 19962289 — intervention group
Group type: EXPERIMENTAL
Intervention: Hibiscus sabdariffa extract powder (HSEP)
Number of subjects: 0
Study 19962289 — intervention group
Group type: EXPERIMENTAL
Intervention: Hibiscus sabdariffa extract powder (HSEP) plus diet
Number of subjects: 0
Study 19962289 — intervention group
Group type: COMPARATOR
Intervention: Preventive treatment (diet)
Number of subjects: 0
Study 18319697 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 20
Study 18319697 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic coronary angiography
Number of subjects: 20
Study 18661258 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein (15 g of whey both before and after exercise)
Number of subjects: 31
Study 18661258 — intervention group
Group type: COMPARATOR
Intervention: Placebo (non-energetic placebo)
Number of subjects: 31
Study 16311444 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyography (EMG) and mechanical myotonometry (MYO, frequency and decrement of decay)
Number of subjects: 0
Study 11532533 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline (25-100 mg/day)
Number of subjects: 22
Study 11532533 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50-150 mg/day)
Number of subjects: 22
Study 11532533 — intervention group
Group type: COMPARATOR
Intervention: Normal control group (n=19)
Number of subjects: 22
Study 9172067 — intervention group
Group type: EXPERIMENTAL
Intervention: MeSH term searches
Number of subjects: 0
Study 9172067 — intervention group
Group type: COMPARATOR
Intervention: Textword searches
Number of subjects: 0
Study 7955872 — intervention group
Group type: EXPERIMENTAL
Intervention: Citramag (2 sachets)
Number of subjects: 196
Study 7955872 — intervention group
Group type: EXPERIMENTAL
Intervention: Picolax
Number of subjects: 196
Study 7955872 — intervention group
Group type: EXPERIMENTAL
Intervention: Picolax with cleansing enema
Number of subjects: 196
Study 7955872 — intervention group
Group type: COMPARATOR
Intervention: Picolax and Citramag
Number of subjects: 196
Study 3442758 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam-Ketamine
Number of subjects: 100
Study 3442758 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl-Methohexital
Number of subjects: 100
Study 12568180 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin 250 mg i.v. every 8 hours
Number of subjects: 21
Study 12568180 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 29439668 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant HIPEC with Mitomycin C (60 min at 42-43 °C) followed by routine adjuvant systemic chemotherapy
Number of subjects: 200
Study 29439668 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (systemic chemotherapy only)
Number of subjects: 200
Study 27173814 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP pretest group
Number of subjects: 401
Study 27173814 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pretest)
Number of subjects: 401
Study 25114132 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g PAS twice daily
Number of subjects: 73
Study 25114132 — intervention group
Group type: COMPARATOR
Intervention: 8 g PAS once daily
Number of subjects: 73
Study 25114132 — intervention group
Group type: COMPARATOR
Intervention: Concurrent efavirenz (EFV) medication
Number of subjects: 73
Study 22369032 — intervention group
Group type: COMPARATOR
Intervention: ICSI using motile spermatozoon with normal morphology injected into metaphase‐II (M‐II) oocyte (Group A1)
Number of subjects: 96
Study 22369032 — intervention group
Group type: COMPARATOR
Intervention: ICSI using spermatozoon showing coiling of tail (Group B1)
Number of subjects: 96
Study 22369032 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSI using spermatozoan with birefringent head (Group A2)
Number of subjects: 96
Study 22369032 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSI using spermatozoan with birefringent head (Group B2)
Number of subjects: 96
Study 20470675 — intervention group
Group type: EXPERIMENTAL
Intervention: 532 nm laser therapy with retinaldehyde-based topical application
Number of subjects: 14
Study 20470675 — intervention group
Group type: COMPARATOR
Intervention: 532 nm laser therapy alone
Number of subjects: 14
Study 20470675 — intervention group
Group type: COMPARATOR
Intervention: Control side (untreated)
Number of subjects: 14
Study 18318871 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing the Risk curriculum
Number of subjects: 1944
Study 18318871 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Reducing the Risk curriculum
Number of subjects: 1944
Study 18318871 — intervention group
Group type: COMPARATOR
Intervention: Standard pregnancy and HIV prevention curriculum
Number of subjects: 1944
Study 15897496 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic bilateral STN stimulation (STN-S)
Number of subjects: 39
Study 15897496 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy alone (control)
Number of subjects: 39
Study 12552351 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of [(123)I]IPT
Number of subjects: 15
Study 12552351 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal children)
Number of subjects: 15
Study 12552351 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-naive children with ADHD
Number of subjects: 15
Study 10330212 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial Action Coding System
Number of subjects: 28
Study 7546496 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium-based diet advised by a nutritionist
Number of subjects: 95
Study 7546496 — intervention group
Group type: COMPARATOR
Intervention: Blood pressure control group
Number of subjects: 95
Study 7546496 — intervention group
Group type: COMPARATOR
Intervention: Time control group
Number of subjects: 95
Study 2028789 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Expiratory Pressure (PEP) mask as a method of chest physiotherapy
Number of subjects: 28
Study 2028789 — intervention group
Group type: EXPERIMENTAL
Intervention: PEP mask in conjunction with Forced Expiratory Technique (FET)
Number of subjects: 28
Study 7317246 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 10 microgram kg‐1 i.v.
Number of subjects: 0
Study 7317246 — intervention group
Group type: COMPARATOR
Intervention: Atropine 20 microgram kg‐1 i.v.
Number of subjects: 0